Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,581 INR | -0.19% | +4.35% | +0.14% |
05-14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
05-13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.14% | 2.58B | |
-20.70% | 7.83B | |
-8.23% | 2.48B | |
-40.47% | 2.46B | |
-12.98% | 1.84B | |
-21.29% | 1.53B | |
-42.17% | 1.22B | |
+16.01% | 1.2B | |
+14.92% | 961M | |
-14.90% | 920M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- CARE Assigns AA Rating on Dr. Lal Pathlabs' Long-term Bank Financing; Outlook Stable